Publications by authors named "S Bouju"
Introduction: In orthopaedics, anterior cruciate ligament (ACL) reconstructions are among the most common surgical interventions. Two methods are preferably used: autografts from the hamstring tendon (HT) or patella tendon (PT). The purpose of this meta-analysis was to compare these two methods when returning to sports.
View Article and Find Full Text PDFObjective: To present the first real-world data of patients with treatment-resistant depression (TRD) treated with esketamine through a French cohort Temporary Authorisation for Use (ATUc) programme.
Methods: In 2019, the French Health Authorities exceptionally granted the first ATUc in psychiatry for TRD patients. Clinical characteristics, safety and efficacy data were reported by physicians.
Purpose: Long-term antipsychotic treatment is key to a positive clinical outcome in schizophrenia. Recent guidelines recommend the prescription of long-acting antipsychotic formulations (LAIs) as early as the first episode in patients with schizophrenia. The OPTIMUS study evaluated real-world use of a new three-monthly paliperidone palmitate formulation (PP3M) in France.
View Article and Find Full Text PDFArticle Synopsis
- Functional remission in schizophrenia, aimed at improving daily functioning, varies significantly in success rates, with around 15% to 51% of patients achieving it.
- A study followed 303 French schizophrenia patients on long-acting injectable treatment for a year, finding 45.1% reached functional remission while 55.1% achieved clinical remission; clinical remission greatly increased the chances of functional remission.
- Key factors influencing functional remission included the duration of the psychotic condition, family support, education level, employment status, initial functioning levels, and insight into their condition, underscoring the need for effective symptom management to enhance recovery.
Purpose/background: The study objective was to compare the impact of being treated by paliperidone palmitate (PP) or risperidone long-acting injection (RLAI) on the length of stay on initial hospitalization, rehospitalization risk, and treatment duration in schizophrenic patients.
Methods: We conducted an observational retrospective cohort study in 43 centers in France, including schizophrenic patients who initiated a treatment by PP or RLAI during initial hospitalization. The follow-up periods started in September 2012 for the RLAI group (median follow-up duration, 233 days) and in June 2013 for the PP group (259 days).